Nagy A. et al: COVIDOUTCOME—estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome, Database (2021)

Menyhárt O. et al: Gene expression based biomarkers designating glioblastomas resistant to multiple treatment strategies, Carcinogenesis (2021)

Bartha and Győrffy: TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissuess. Int J Mol Sci (2021)

Nagy et al: Pancancer survival analysis of cancer hallmark genes.Sci Rep (2021)

Our new analysis platform COVIDOUTCOME can link mutation in SARS-CoV-2 to clinical outcome - click image to visit site.

Nagy et al: Different mutations in SARS-CoV-2 associate with severe and mild outcome. Int J Antimicrob Agents (2021)

Menyhárt and Győrffy: Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis, Computational and Structural Biotechnology Journal (2021)

Nagy and Győrffy: muTarget: A platform linking gene expression changes and mutation status in solid tumors. Int J Cancer (2021)

Pongor L, Munkácsy G, et al. Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting, Scienfic Reports (2020)

Menyhárt, Carouso-Peck et al: Contingent parental responses are naturally associated with zebra finch song learning, Animal Behaviour (2020)